Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens
Cell · 2025-11 · 188 (24) · 6737-6753.e18
DOI: 10.1016/j.cell.2025.09.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-11. Verfasst von Raymond W Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, Irvine, Irvine, CA, USA; GlyTR Therapeutics Inc., Irvine, CA, USA. Hauptthemen laut MEDLINE: Antigens, Tumor-Associated, Carbohydrate, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NCI NIH HHS, National Cancer Institute Cancer Moonshot.
Abstract (Originalsprache)
Bispecific antibodies and chimeric antigen receptor T cells are some of the most potent cancer immunotherapeutics in clinical use, yet most cancers remain poorly targetable. High-affinity antibodies required to maximize killing detect low antigen expression in normal tissue, risking "on-target, off-cancer" toxicity. This compels identification of cancer-restricted cell-surface protein antigens, which are rare. Tumor-associated carbohydrate antigens (TACAs) are the most abundant and widespread cancer antigens known but are poorly targetable by antibodies. Here, we describe glycan-dependent T cell recruiter (GlyTR) pan-cancer immunotherapeutics that utilize high-avidity "velcro-like" lectin binding to kill cells with high but not low TACA expression. GlyTR1 and GlyTR2 bind immunosuppressive β1,6GlcNAc-branched N-glycans or multiple TACAs (Tn, sialyl-Tn, LacDiNAc, and GD2), respectively, overcome immunosuppressive mechanisms in the tumor microenvironment and trigger target-density-dependent T cell-mediated pan-cancer killing, yet they lack toxicity in mice with human-like TACA expression. Density-dependent lectin binding to TACAs provides highly potent and safe pan-cancer immunotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of California, Irvine, Irvine, CA, USA; GlyTR Therapeutics Inc., Irvine, CA, USA.
- Department of Neurology, University of California, Irvine, Irvine, CA, USA.
- Department of Pathology & Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.
- Department of Neurology, University of California, Irvine, Irvine, CA, USA; Department of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA, USA. Electronic address: mdemetri@uci.edu.
Förderung
- NCATS NIH HHS
- NCI NIH HHS
- National Cancer Institute Cancer Moonshot
- University of California, Irvine
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- National Center for Advancing Translational Sciences
- Institute of Clinical and Translational Sciences
Zitieren
APA
Zhou, R. W., Purohit, P. K., Kim, J. H., Lee, S. U., Burshteyn, N., Tifrea, D., Cordon, A., Grigorian, A., Newton, B. L., Edwards, R. A., & Demetriou, M. (2025). Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Cell, 188(24), 6737-6753.e18. https://doi.org/10.1016/j.cell.2025.09.001
Vancouver
Zhou RW, Purohit PK, Kim JH, Lee SU, Burshteyn N, Tifrea D, et al. Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Cell. 2025;188(24):6737-6753.e18. doi:10.1016/j.cell.2025.09.001
BibTeX
@article{Zhou2025,
author = {Zhou, Raymond W and Purohit, Paresh Kumar and Kim, Jai Hyun and Lee, Sung-Uk and Burshteyn, Nicole and Tifrea, Delia and Cordon, Andres and Grigorian, Ani and Newton, Barbara L and Edwards, Robert A and Demetriou, Michael},
title = {Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens},
journal = {Cell},
year = {2025},
volume = {188},
number = {24},
pages = {6737--6753.e18},
doi = {10.1016/j.cell.2025.09.001}
}
EUVIMED